Introduction
Asbestos fibers cause non-malignant diseases (asbestosis) as well as malignant ones such as bronchogenic carcinoma and malignant mesotheliomas Robledo and Mossman, 1999) . However, the underlying molecular mechanisms of fiber carcinogenesis are not clear. There is accumulating evidence that asbestos can modify cellular function by stimulating signal transduction cascades including membrane bound tyrosine kinase (TK), protein kinase C (PKC), and mitogen activated protein kinase (MAPK). Activation of these signaling pathways results in the upregulation of transcription factors such as AP-1 and nuclear transcription factor kappa-B (NF-kB) and induces the expression of a number of genes governing cellular inflammation, proliferation and apoptosis (Zanella et al., 1996; Mossman et al., 1997; Kamp and Weitzman, 1999) .
Asbestos induces a range of DNA damages including single DNA base substitutions, intrastrand linking, point mutations and large chromosomal deletions (Jaurand, 1997) . Previous studies from our laboratory have shown that asbestos is a chromosomal mutagen and induces predominantly multilocus deletion (Hei et al., 1992; Xu et al., 1999) . These findings are consistent with cytogenetic data showing that most malignant mesotheliomas have complex karyotypes resulting from the accumulation of numerous genetic events (Murthy and Testa, 1999) . Deletions of specific chromosomal regions in the short arms of chromosomes 1, 3 and 9 and the long arm of chromosome 6 are frequently observed (Pass and Mew, 1996) . Since many of these regions contain known or suspected tumor suppressor genes, these results suggest that loss and/or inactivation of tumor suppressor genes are possible mechanisms of fiber carcinogenesis. However, several common tumor suppressor genes, such as p53, Rb and p16INK4, have not been linked to asbestos-related pulmonary malignancies (Gerwin, 1994; Ni et al., 2000) , suggesting perhaps, that some yet unidentified tumor suppressor(s) be involved in the carcinogenic process.
One of the main difficulties in studying mechanisms of fiber carcinogenesis is the lack of a suitable human cell model whereby the molecular changes associated with various transformed stages can be examined. We showed previously that chrysotile asbestos induced malignant transformation of human papillomavirus immortalized human bronchial epithelial (BEP2D) cells in a step-wise fashion and produced progressively growing tumors in nude mice (Hei et al., 1997 . Results of cell fusion studies between asbestos-induced tumorigenic and parental BEP2D cells demonstrated that the tumorigenic phenotype induced by chrysotile treatment could be completely suppressed by fusion with non-tumorigenic control cells . These studies suggest that non-tumorigenic cells can complement the loss of functions of gene products in tumorigenic cells and provide some indications that loss of suppressor function as an important mechanism of fiber carcinogenesis. In addition, our cytogenetic analyses on asbestos-induced tumorigenic BEP2D cell lines have shown that loss of one or two copies of chromosome 5, the monosomy of chromosome 19, and increased trisomy of chromosome 8 are the most common chromosomal changes (Suzuki et al., 2001) . Using cDNA expression arrays, we have identified a series of genes that are differentially expressed between control and asbestos-induced tumorigenic BEP2D cells, including up-regulation of c-fos and NF-kB as well as down-regulation of DCC, p21cip1 and Betaig-h3 genes Piao et al., 2001) . Since Betaig-h3 gene is mapped to long arm of chromosome 5, which is predominantly lost in asbestos-induced tumorigenic cell lines (Suzuki et al., 2001) , it is likely that decreased expression of this gene plays a casual role in asbestosinduced cellular transformation.
Betaig-h3 is a secreted protein induced by transforming growth factor-b (TGF-b) in human adenocarcinoma cells as well as other human cell types (Skonier et al., 1992) . This protein is highly conserved with four internal homologous domains, the last of which contains an Arg-Gly-Asp (RGD) sequence which serve as a ligand recognition site for several integrins. Mutations or altered expression of this gene have been linked to the pathogenesis of human corneal dystrophy and osteogenesis (Bron, 2000; Kim et al., 2000) . Although transfection of Betaig-h3 gene into Chinese Hamster Ovary (CHO) fibroblasts has been shown to markedly reduce their tumorigenicity in nude mice (Skonier et al., 1994) , there is little or no information on the effect of this gene in human cancer. In the present study, we show that ectopic expression of Betaig-h3 gene in asbestos-induced tumorigenic human bronchial epithelial cells significantly suppresses their in vivo tumorigenicity. Furthermore, Betaig-h3 expression is either decreased or absent in 14 human tumor cell lines examined compared with normal human cells. Our finding strongly suggests that Betaig-h3 gene functions as a tumor suppressor and loss of its expression plays a critical role in fiber carcinogenesis.
Results
Betaig-h3 gene is down-regulated in asbestos-induced tumorigenic cell lines Tumorigenic cells were previously derived by treatment of exponentially growing BEP2D cells with a 4 mg/cm 2 dose of chrysotile fibers for 7 days (Hei et al., 1997) . Tumors 41 cm in diameter were resected from nude mice and used to establish independently generated cell lines . Fusion cell lines were generated by fusion of the highly malignant AsbTB2A cells with control BEP2D cells using polyethylene glycol as described Piao et al., 2001) . The resultant fusion cells were shown to be nontumorigenic when inoculated into nude mice . By using cDNA microarrays, we identified a series of genes that were differentially expressed in asbestos-induced tumorigenic cell lines relative to parental BEP2D cells . Among these genes, Betaig-h3 expression was found to be markedly decreased in tumorigenic cells. As shown in Figure 1 , the expression level of Betaig-h3 gene was further confirmed by Northern blot using mRNAs obtained from control BEP2D cells, non-tumorigenic transformed cells, early and late passage of transformed cells, five tumorigenic cell lines (AsbTE, AsbTB, AsbTB2A, AsbTB2B and AsbTE2A) and a fusion cell line. Expression levels of the Betaig-h3 gene were not significantly different between the non-tumorigenic, early and late passage transformed cells relative to control BEP2D cells. However, the Betaig-h3 expression was downregulated about 7 -8-fold in all five tumorigenic cell lines and restored to control level in the fusion cell line examined ( Figure 1 ). Similar findings were also obtained with three other independently-generated, non-tumorigenic fusion cell lines (data not shown). The data indicate that decreased expression of Betaig-h3 gene may be related to the acquisition of malignant phenotype in BEP2D cells induced by asbestos.
Ectopic expression of Betaig-h3 gene in asbestos-induced tumorigenic cells inhibits their colony-forming efficiency in soft agar
To ascertain the tumor suppressive effect of Betaig-h3 gene, we ectopically re-expressed the gene in a highly malignant cell line (AsbTB2A) using pRc/CMV2-betaigh3 expression vector. Two G418 resistant colonies (AsbTB2A-clone 5 and AsbTB2A-clone 11) that expressed different levels of Betaig-h3 gene were chosen for further studies. From the Northern and Western blotting results (Figure 2 ), the parental TB2A cells and TB2A-pRc/CMV2 cells expressed a low, detectable, and similar level of Betaig-h3 gene. After transfection, the expression of Betaig-h3 gene in TB2A-clone 5 cells was restored to a level similar to that of control BEP2D cells, whereas in TB2A-clone 11 cells it was twofold higher than control. The mRNA and Figure 1 Northern blotting analysis of Betaig-h3 gene in early and late passage transformed but non-tumorigenic cells, asbestos-induced tumorigenic cell lines and a fusion cell line relative to control BEP2D cells. Aliquots of 2.5 mg mRNAs were blotted and hybridized to 32 P-labeled cDNA probes. After stripping, the membranes were rehybridized to human b-actin which is used as control (Hei et al., 1997) , TB2A-clone 5 and clone 11 cells showed a 1.5-fold lower in cell number ( Figure  3a ). As shown in Table 1 , the colony-forming efficiency of Betaig-h3 transfected cells in soft agar (0.2 -0.3%) was significantly decreased compared with parental TB2A cells (2.6%, P50.01). The data indicate that ectopic expression of Betaig-h3 gene in TB2A tumorigenic cells resulted in a significant lower ability of anchorage independent growth.
Tumorigenicity of asbestos-induced tumorigenic cells was significantly attenuated after Betaig-h3 gene transfection
To determine whether ectopic expression of Betaig-h3 gene in asbestos-induced TB2A tumorigenic cells suppresses tumor formation in vivo, we injected 5610 6 of each of the following cell lines into nude mice, control BEP2D cells, AsbTB2A cells, TB2A-pRc/ CMV2 and Betaig-h3 transfected cells (TB2A-clone 5 and TB2A-clone 11). The tumor volumes were measured weekly during the experiments. As shown in Table 1 , no tumor (0/10 mice) was detected in mice injected with the parental BEP2D cells after more than 20 weeks. However, 10/10 mice that were injected with either TB2A or TB2A-pRc/CMV2 tumorigenic cells developed progressively growing tumors at 4 weeks, with average volumes of 544.9 and 428.8 mm 3 , respectively. In contrast, only 5/10 mice injected with TB2A-clone 5 and 7/10 mice injected with TB2A-clone 11 cells formed small tumor nodules at 4 weeks, with an average volume of 59.1 mm 3 which was significantly smaller than that of the parental TB2A cells (P50.01). In addition, the tumor growth at each time point } Betaig-h3 expression is ubiquitously expressed in normal human tissues and is decreased or absent in various human tumor cell lines
We checked the expression of Betaig-h3 gene in different normal human tissues and 14 human tumor cell lines. We found that Betaig-h3 expression was ubiquitously expressed in normal tissues, with high expression levels in heart, placenta, liver, spleen, small intestine and peripheral blood leukocyte. Other tissues such as pancreas, kidney, thymus, testis and ovary expressed comparably lower levels of the gene, with the exception of brain that showed no Betaig-h3 expression (Figure 4) . In contrast, decreasing or loss of Betaig-h3 expression was observed in all tumor cell lines when compared with their normal human cells or tissues ( Figure 5 ). Among the six lung tumor cell lines examined, five of them including A549, H460, H1299, H522 and H810 were derived from lung epithelial cells. Therefore, we chose normal human bronchial epithelial (NHBE) cells as control. We found a 3 -5-fold lower expression level of this gene in three lung tumor cell lines (A549, H460 and H1299) and one colon cancer cell line (HT29), very low or undetectable levels in other tumor cell lines including lung cancer (H522, H810, H1417), leukemia (K562, Jurkat), stomach cancer (SNU16), breast cancer (MCF-7, MDA-MB-231, MDA-MB-361) and kidney cancer (293T). MCF-10F, which is spontaneously immortalized, nontumorigenic mammary epithelial cell line, had a similar level of Betaig-h3 expression as normal HMEC cells.
Discussion
Asbestos fibers represent a complex group of minerals that are associated with the development of malignant and non-malignant diseases . The persistent induction of c-fos, c-jun, and other stress-related DNA-binding proteins by asbestos signals chronic inflammation and are consistent with an increased level of reactive oxygen species reported in asbestos treated cultures (Robledo and Mossman, 1999; Xu et al., 1999) . There is evidence that asbestos stimulates cellular proliferation in mesothelial cells which may facilitate clonal expansion of putative transformed cells to result in malignant phenotype (Heintz et al., 1993) . Although there are data in support of a possible role of tumor suppressor gene(s) in fiber carcinogenesis (Murthy and Testa, 1999; Zhao et al., 2000) , there has been no clear association of either known oncogenes or tumor suppressor genes with the development of asbestos associated malignancies (Kane, 1996; Ni et al., 2000) .
We have previously shown that down-regulations in the expression of DCC, p21cip1 and Betaig-h3 genes in asbestos-induced tumorigenic BEP2D cells Piao et al., 2001) . DCC is a known tumor suppressor gene and loss of its expression has been shown to occur in many human tumors (Fearon and Pierceall, 1995) . However, we have not been able to demonstrate that ectopic expression of wild type DCC gene can suppress the tumorigenic phenotype in asbestos-induced tumor cells (data not shown). The result suggests that DCC gene does not play a causal role in asbestos-induced tumorigenic conversion of BEP2D cells. On the other hand, we have recently demonstrated that loss of one or two copies of chromosome 5, where Betaig-h3 is located, is a common cytogenetic alteration among fiber induced tumorigenic cells (Suzuki et al., 2001) . Until now, there has been no published report on its role as a tumor suppressor in human cancers. In this study, ectopic expression of Betaig-h3 gene by transfecting pRc/ CMV2-betaigh3 vector in tumorigenic cells significantly inhibits colony-forming efficiency in soft agar and tumor growth in nude mice relative to parental tumorigenic cells. The finding provides compelling evidence of a possible tumor suppressor role of the Betaig-h3 gene in asbestos-induced malignant conversion of human BEP2D cells. The data support the hypothesis that persistent activation of proto-oncogenes (such as c-fos) and inactivation of tumor suppressor genes (such as Betaig-h3 in this model) may cooperate in a multistep process to regulate critical events intrinsic to the pathogenesis of asbestosassociated human lung cancer .
Cytokines are a major class of inflammatory signaling molecules that play a pivotal role in Figure 4 Total mRNA levels of Betaig-h3 gene in normal human tissues. The multiple tissue blots was purchased from Clontech. High expression levels of Betaig-h3 were found in heart, placenta, liver, spleen, small intestine and leukocyte Figure 5 Total mRNA levels of Betaig-h3 gene in various human tumor cell lines. 2.5 mg mRNAs were isolated from lung cancer cell lines (A549, H460, H1419, H522, H810, H1417), leukemia (K562, Jurkat), colon cancer (HT29), stomach cancer (SNU16), breast cancer (MCF-7, MDA-MB-231, MDA-MB-361) and kidney cancer (293T). Normal human bronchial epithelial (NHBE) cells, human mammary epithelial cells (HMEC), peripheral blood leukocyte, colon, stomach and kidney tissues were used as various controls. The blots were hybridized to 32 P-labeled cDNA probes. After stripping, the membranes were rehybridized to human b-actin which is used as control as described above Betaig-h3 gene suppresses tumorigenicity Y Zhao et al asbestos-induced cellular proliferation leading to preneoplastic and neoplastic transformation (Brody et al., 1997) . Transforming growth factor b (TGF-b) is a potent cytokine involved in the induction of extracellular matrix production and stimulation of epithelial and mesenchymal proliferation (Robledo and Mossman, 1999) . Upregulation of TGF-b has been observed in fibrotic lungs of chrysotile asbestos workers (Jagirdar et al., 1997) as well as in rat tracheal explants exposed to asbestos fibers (Perdue and Brody, 1994) . Furthermore, TGF-b contributes not only to the pathogenesis but, possibly, to the aggressive growth of mesothelioma as well (Fitzpatrick et al., 1995) . Betaig-h3, as one of the downstream genes of TGF-b, could be induced in many human tissues (Skonier et al., 1992) . It is postulated that decreased expression of Betaig-h3 gene may be partly due to the dysregulation of the TGF-b pathway. However, we have not found any significant changes in the expression of either TGF-b or its receptor at the both mRNA and protein levels in asbestos-induced tumorigenic BEP2D cell lines (data not shown). In addition, both control and tumorigenic BEP2D cells were sensitive to the growth inhibitory effect of exogenous TGF-b1 (data not shown). These data suggest that downregulation of Betaig-h3 gene mainly results from loss of chromosome 5 in BEP2D cell model. There is evidence that chromosome 5q31, where Betaig-h3 gene has been regionally mapped to, is often deleted in leukemias, myelodysplastic syndromes and many human cancers such as renal cell, esophageal and lung carcinoma (Brezinova et al., 2000; Peralta et al., 1998; Wu et al., 1998) , suggesting that deletion of Betaig-h3 gene is a frequent event in human cancer. This is further supported by our data that Betaig-h3 gene is ubiquitously expressed in many human normal tissues, whereas decreased or even loss of Betaig-h3 gene expression was found in 14 human tumor cell lines comprised of several histological types. Furthermore, reduced expression of this gene has been reported in embryonal rhabdomyosarcoma cell lines and mesenchymal tumors (Genini et al., 1996; Schenker and Trueb, 1998) . These data indicate that loss of Betaig-h3 expression contributes not only to asbestos fiber-induced neoplastic transformation in BEP2D cell model, but also human tumors in general. Since high levels of Betaig-h3 mRNA expression are found in heart, placenta, liver, spleen, small intestine and leukocyte, many of which are important components of immune system. Whereas neoplastic cells develop various strategies to escape immune surveillance (Salih and Nussler, 2001) , it is possible that Betaig-h3 protein modulates tumor progression by regulating in vivo immune functions.
Previous studies suggested that betaig-h3 protein might affect the interaction of cells with their extracellular matrix by regulating the expression of integrin receptor expression (Billings et al., 2000a,b) . To ascertain the specific receptor(s) for betaig-h3, we screened the mRNA expression of a1-a6, av and b1-b3 integrin subunits in Betaig-h3-transfected cells compared with control BEP2D and parental tumor cells by Northern blot. There was no significant change in the expression of any of these integrin subunits (data not shown). The data suggest that others, yet unidentified downstream effector(s), mediate the tumor suppressor function of Betaig-h3 gene.
Although BEP2D cells are immortalized by HPV-18 that disturbs both normal p53 and RB functions, they are non-tumorigenic even in late passage (Hei et al., 1997 Willey et al., 1991) . This suggests that additional genetic alterations are needed in the tumorigenic conversion of these cells by asbestos. Our present findings that expression of the Betaig-h3 gene is similar between BEP2D and normal human bronchial epithelial cells, and that ectopic expression of Betaig-h3 gene suppresses tumorigenic phenotype suggest that down-regulation of Betaig-h3 gene occurs at the late stage of transformation and contributes to the acquisition of tumorigenic phenotype induced by asbestos.
Materials and methods

Cell lines
The human papillomavirus-immortalized human bronchial epithelial (BEP2D) cells (Willey et al., 1991) and their asbestos induced tumorigenic variants (Hei et al., 1997; Piao et al., 2001) were maintained in serum-free LHC-8 medium supplemented with various growth factors (Biofluid, Rockville, MD, USA). Primary human bronchial epithelial (NHBE) cells and human mammary epithelial cells (HMEC) were purchased from Clonetics BioWhittaker (Walkersville, MD, USA) and were maintained in serum-free BEGM and MEBM medium supplemented growth factors. Human cancer cell lines (A549, HT29, 293T, MCF-7, MDA-MB-231, MDA-MB-361) were grown in 10% fetal bovine serum/ DMEM; human cancer cell lines (H460, H1299, H522, H1417, K562, Jurkat, SNU-16) were grown in 10% fetal bovine serum/RPMI 1640; human lung large cell carcinoma H810 was maintained in HITES medium supplemented with insulin, transferrin, sodium selenite, hydrocortisone and betaestradiol (Clonetics Bio Whittaker, Walkersville, MD, USA). MCF-10F cells were cultured in DMEM/F12 (1:1) medium supplemented with 10% fetal bovine serum, 10 mg/ml insulin, 0.5 mg/ml hydrocortisone and 0.02 mg/ml epidermal growth factor.
Isolation of poly(A)
+ RNA and Northern blotting
Total RNA was prepared using TRIzol reagent (Life Technologies, Grand Island, NY, USA) according to manufacturer's instruction. Poly(A) + mRNA was then enriched using an oligotex mRNA kit (Qiagen, Valencia, CA, USA). The mRNA from human peripheral blood leukocyte was ordered from Clontech and mRNAs from normal human tissues (colon, stomach, kidney) were ordered from Ambion. For Northern blotting, 2.5 mg mRNA was denatured and separated on a 1% denaturing agarose formaldehyde gel. The mRNAs were then transferred to a nylon membrane (Millipore, Bedford, MA, USA) by downward capillary blotting in 206SSC followed by UV crosslinking. Betaig-h3 cDNA was labeled with a-32 P-dCTP using a random primed DNA labeling kit (The Diagnostic Betaig-h3 gene suppresses tumorigenicity Y Zhao et al Corporation, Indianapolis, USA). Human multiple tissue blot membranes (Clontech, Palo Alto, CA, USA) were prehybridized for 30 min and then hybridized with probe in hybridization solution. The blots were washed twice in 26SSC, 0.1% SDS at room temperature for 15 min followed by washing twice in 0.26SSC, 0.1% SDS at 558C for 15 min. The band intensities were evaluated by phosphorimaging and normalized to the b-actin expression level which was used as control.
Cloning and sequencing of Betaig-h3 cDNA
The first strand cDNA was synthesized from 0.2 mg poly(A) + RNA isolated from NHBE cells using Superscript II reverse transcriptase and oligo(dT) primer (Life Technologies Inc.). Human Betaig-h3 cDNA was then PCR-amplified using highfidelity MasterAmp TM DNA polymerase (Epicenter, Madson, WI, USA) and synthetic primers (5'-GTTAAGCTTGCTTG-CCCGTCGGTCGCTAGCT-3', 5'-GCTCTAGAGCCTCC-AAGCCACGTGTAGATGT-3') that included HindIII and XbaI restriction enzyme recognition sites. The amplified whole length cDNA was subcloned into the HindIII and XbaI-digested pRc/CMV2 expression vector (Invitrogen). The sequence analysis showed that the protein sequence is 100% identical with the report in Gene bank except several modified nucleotide sites such as 698 (C?G), 1118 (C?T) and 1667 (T?C).
Transfection of AsbTB2A tumorigenic cells with pRc/CMV2-Betaig-h3 vector
Asbestos-induced tumorigenic cells (AsbTB2A) were plated at 1.5610 6 per 60 mm dish in serum-free LHC-8 medium. When reaching 70 -80% confluence, they were transfected with either pRc/CMV2-Betaigh3 or pRc/CMV2 vector (2 mg/dish) for 24 h using lipofectamin (Life Technologies) according to the manufacturer's instruction. The cells were split at 1 : 10 and cultured in the medium containing 500 mg/ml of the G418 (Life Technologies) for 21 days. Resistant colonies were isolated and maintained in the presence of 300 mg/ml of G418.
Western blotting
For analysis of Betaig-h3 protein expression, conditioned medium was collected when the cells grow near confluent and the protein was then concentrated using SP sepharose (Amersham) and eluted using SDS sample buffer by boiling 5 min. The protein concentrations were measured by Bio-Rad DC protein assay kit. Samples containing equal amounts of proteins were fractionated by SDS -PAGE gel, transferred onto Hybond membrane, and immunoblotted with 1 : 1000 dilution of anti-Betaig-h3 human polyclonal antibody (kindly provided by Dr Paul C Billings). Peroxidase-conjugated antirabbit IgG was used to detect Betaig-h3 level by ECL procedure (Amersham).
In vitro growth rate
Growth curve of Asbestos-induced tumorigenic cells (AsbT-B2A), empty vector or Betaig-h3 transfected tumorigenic cells were performed by plating 5610 4 cells into 25 cm 2 flask. Cell numbers were determined using Coulter Counter. The results at each time point were the mean value of eight cultures from two independent experiments.
Anchorage-independent growth and tumorigenicity in nude mice
Anchorage-independent assays were performed by plating the control BEP2D cells, asbestos-induced tumorigenic cells (AsbTB2A), empty vector-or Betaigh3-transfected tumorigenic cells in 0.35% agar on top of a bottom layer of 0.7% agar. Colonies 510 cells in number were counted after 4 weeks. Tumorigenicity assay was performed as described previously (Hei et al., 1997; Zhao et al., 2000) . Betaigh3-or empty vector-transfected tumorigenic cells were injected subcutaneously into the left flank of nude mice. Tumors were palpated and measured with calipers and tumor volume was calculated using the formula (longest diameter6shortest diameter 2 )60.5. Control animal were inoculated with either control BEP2D cells or asbestos-induced tumorigenic cells. For each cell line, two independent experiments were performed.
